Actionable insights straight to your inbox

Equities logo

Veracyte Partners with AstraZeneca Unit to Provide Genomic Data to Develop Oncology Therapeutics

Multi-year deal with Acerta Pharma, AstraZeneca's hematology research and development arm.
Veracyte ($VCYT) reduces unnecessary surgeries through molecular cytology diagnostics. Eight other operating company IPOs are scheduled for this week. The full IPO calendar can be found at